Author:
Hort Simon,Sanges Carmen,Jacobs John J.L.,Hudecek Michael,Schmitt Robert H.
Funder
Fraunhofer-Institut für Zelltherapie und Immunologie
Fundació Clinic per la Recerca Biomèdica
Foundation for Research and Technology-Hellas
University College London
Horizon 2020 Industrial Leadership
European Commission
Reference37 articles.
1. Euroean Medicines Agency, 2022. EMA/188757/2022 Kymriah (tisagenlecleucel): An overview of Kymriah and why it is authorised in the EU. https://www.ema.europa.eu/en/documents/overview/kymriah-epar-medicine-overview_en.pdf. Accessed 31 January 2023.
2. Janeway's immunobiology;Murphy,2017
3. Production and Application of CAR T Cells: Current and Future Role of Europe;Vucinic;Frontiers in medicine,2021
4. Toward Rapid, Widely Available Autologous CAR-T Cell Therapy -Artificial Intelligence and Automation Enabling the Smart Manufacturing Hospital;Hort;Frontiers in medicine,2022
5. Addressing Pressing Needs in the Development of Advanced Therapies;Morrow;Frontiers in bioengineering and biotechnology,2017